We are live on
!
Find out more
PCM
Parsons Capital Management Portfolio holdings
AUM
$2.21B
1-Year Est. Return
28.12%
This Fund
S&P 500
This Quarter
Est. Return
+12.76%
1 Year Est. Return
+28.12%
3 Year Est. Return
+84.89%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.13%
AUM
$996M
AUM Growth
+$73M
(+7.9%)
Cap. Flow
-$4.39M
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
32.34%
Holding
361
New
17
Increased
88
Reduced
159
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relmada Therapeutics
RLMD
|
+$11.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$3.4M |
| 3 |
Truist Financial
TFC
|
+$2.17M |
| 4 |
Fidelity MSCI Energy Index ETF
FENY
|
+$1.55M |
| 5 |
IBM
IBM
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$6.06M |
| 2 |
3M
MMM
|
+$6.04M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$2.12M |
| 4 |
Constellation Brands
STZ
|
+$1.69M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 13.59% |
| 3 | Financials | 12.59% |
| 4 | Industrials | 12.28% |
| 5 | Consumer Discretionary | 6.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
| – | – |
-11,000
| Closed | -$101K |
|
352
Compass Minerals
CMP
$1.15B
| – | – |
-5,919
| Closed | -$334K |
|
353
First Trust North American Energy Infrastructure Fund
EMLP
$4.08B
| – | – |
-8,000
| Closed | -$205K |
|
354
Enterprise Products Partners
EPD
$81.7B
| – | – |
-10,230
| Closed | -$292K |
|
355
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
| – | – |
-9,250
| Closed | -$335K |
|
356
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.77B
| – | – |
-33,082
| Closed | -$981K |
|
357
Wheaton Precious Metals
WPM
$60.9B
| – | – |
-50,896
| Closed | -$1.34M |
|
358
Weyerhaeuser
WY
$18.4B
| – | – |
-43,085
| Closed | -$1.19M |
|
|
WRK
359
DELISTED
WestRock Company
WRK
| – | – |
-5,895
| Closed | -$215K |
|
|
STI
360
DELISTED
SunTrust Banks, Inc.
STI
| – | – |
-30,735
| Closed | -$2.12M |
|
|
CELG
361
DELISTED
Celgene Corp
CELG
| – | – |
-61,050
| Closed | -$6.06M |
|
Similar funds
WCMNY
IFA
DPCM
RAM
GC
ORCP
NP
GF
Parsons Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Parsons Capital Management held 361 positions worth $996M, up 7.9% from $923M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Parsons Capital Management's Q4 2019 filing shows 17 new, 88 increased, 159 reduced and 12 closed positions. Its largest new stake was Relmada Therapeutics: 366,933 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $6.06M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Parsons Capital Management's largest Q4 2019 buy was Relmada Therapeutics: 366,933 shares worth $14.3M.
- Parsons Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.4M increase.
- Parsons Capital Management's biggest Q4 2019 reduction was 3M, cutting an estimated $6.04M.
- Parsons Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $6.06M.
- Parsons Capital Management's ten largest holdings make up 32% of its $996M portfolio in Q4 2019.
- Parsons Capital Management opened 17 new positions and closed 12 in Q4 2019.
- Parsons Capital Management's portfolio value rose 7.9% quarter-over-quarter to $996M.
Based on Parsons Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.